Clinical trial
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients…
NCT00076726 · Centocor, Inc., Industry · Terminated
Key facts
| NCT number | NCT00076726 |
|---|---|
| Title | A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis |
| Official title | A Randomized, Double-Masked, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Infliximab in Subjects With Giant Cell Arteritis |
| Lead sponsor | Centocor, Inc., Industry |
| Collaborators | The Cleveland Clinic |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Giant Cell Arteritis |
| Intervention type | Drug |
| Interventions | Infliximab |
| Enrollment | 44 |
| Start date | Nov 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Feb 4, 2004 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: